ERIN SMITH: Open Payments
NPI 1588910467 · TOLEDO, OH. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$592 in 12 payments from 7 companies in 2025. Trend: 2023 $487 · 2024 $451 · 2025 $592
Food & beverage: $592
| Company | Payments | Amount |
|---|---|---|
| E.R. Squibb & Sons, L.L.C. | 2 | $244 |
| ABBVIE INC. | 4 | $156 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 1 | $106 |
| Otsuka America Pharmaceutical, Inc. | 2 | $37 |
| Teva Pharmaceuticals USA, Inc. | 1 | $24 |
| Vanda Pharmaceuticals Inc. | 1 | $18 |
| Corium, LLC | 1 | $6 |
Products named: COBENFY, VRAYLAR, CAPLYTA, AUSTEDO XR, ABILIFY ASIMTUFII, HETLIOZ, REXULTI, Azstarys.
Industry payments across OH — which companies pay providers there.
